Home>Topics>Funds>OppenheimerFunds

OppenheimerFunds

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. OIGCX Oppenheimer International Growth C Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Thu, 7 Jan 2010

    used the same basic strategy since he started.Reasonably priced.Leverages the thinking of Oppenheimer's talented global equity team.Gives investors market-cap diversification and some emerging-markets exposure.George Evans has been the fund's manager since its inception in March ..... since its inception in March 1996 and has managed international accounts at Oppenheimer Funds since 1991. When Bill Wilby, longtime manager of Oppenheimer Global OPPAX, stepped down, Evans assumed more management duties on Oppenheimer's global equity team. That team boasts several experienced and talented investors, including Frank Jennings and Rajeev Bhaman.USAOIGAXCore. Although the fund owns healthy ..... the portfolio contains some richly priced names. Evans generally doesn't hedge currencies. Oppenheimer levies redemption fees and uses fair-value pricing on an as-needed basis.

  2. OIMBX Oppenheimer Limited Term Municipal B Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Wed, 30 Dec 2009

    to high volatility and losses.Strong performance under current management.Experienced management.Ron Fielding, head of Oppenheimer's municipal-bond team, retired in May 2009, leaving 16-year firm veteran Dan Loughran as his successor. There are six portfolio managers and nine credit ..... more conservative portfolio construction than either of its high-yield muni siblings from Oppenheimer. Still, management won't hesitate to overweight certain sectors it believes offer the most attractive risk/reward characteristics.This fund must store 95% of its ..... makes it tamer than most other high-yield municipal-bond funds and the other offerings in the Oppenheimer Rochester municipal lineup, which have longer average maturities and more exposure to low-quality debt. Nonetheless, the fund still has considerable risks with big bets

  3. OTFBX Oppenheimer AMT-Free Municipals B Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Wed, 30 Dec 2009

    fund, which he's run since January 2005. The Rochester team also runs other Oppenheimer muni funds, including Rochester Fund Municipals RMUNX and Oppenheimer Limited Term New York Municipal LTNYX.USAOPTAXSupporting Player. This fund's large stake in lower-rated bonds and hefty holdings in inverse floating-rate notes make ..... one's muni portfolio.SupportingLead manager Troy Willis works within the investing framework of Oppenheimer's tax-free investing team, led by Dan Loughran. Willis employs a high-income focus and is supported by a team with a reputation for ..... Oppenheimer AMT-Free Municipals' boldness leaves it open to extremes.

  4. New Morningstar Analyst Report - Apple, Inc.

    Stock Reports

    Thu, 21 Jan 2010

    Cook is COO, having come to Apple from Compaq in 1998. Peter Oppenheimer is CFO and has been with the company since 1996. Nevertheless, Jobs is irreplaceable, and his departure would have a detrimental long-term

  5. OMSOX Oppenheimer Main St Opportunity A Fund Analysis, Report, Research, 5 Star Rating – Morningstar

    Fund Reports

    Mon, 5 Oct 2009

    a 12-person team of analysts and managers who moved with him to Oppenheimer; one of them, Anthony Gennaro, is his comanager on this fund.USAOMSOXSupporting PlayerSupportingMani Govil, formerly of RS Large Cap Alpha, is taking over this ..... successful in the past. This is the all-cap version of the large-cap Oppenheimer Main Street.This fund's new lead manager, Mani Govil, employs a strategy that combines quantitative and fundamental analysis. After narrowing down the fund's ..... from across the market-cap spectrum rather than mainly large caps as in Oppenheimer Main Street.

  1. IPO Preview: Foamix Pharmaceuticals

    Headlines

    Thu, 18 Sep 2014

    IPO calendar is available at IPOpremium SEC Documents Manager, Co-Managers: Barclays, Cowen & Company Joint Managers: Oppenheimer & Co., Maxim Group LLC End of lockup (180 days): Tuesday, March 17, 2015 End of 25-day quiet period: Monday, October

  2. IPO Preview: Viking Therapeutics

    Headlines

    Thu, 18 Sep 2014

    for Thursday, Sept. 18, 2014. The full IPO calendar is available at IPOpremium SEC Documents Manager, Co-Managers: Oppenheimer & Co., Roth Capital Joint Managers: Craig-Hallum Capital Group, MLV & Co, Summer Street Research Partners End of lockup

  3. Steer Clear Of Viking Therapeutics' IPO

    Headlines

    Tue, 16 Sep 2014

    at $11 per share, VKTX will command a market value of $167 million. VKTX filed on July 1, 2014. Lead Underwriters : Oppenheimer and Co., Inc; Roth Capital Partners, Inc Underwriters : Craig-Hallum Capital Group LLC; MLV & Co. LLC; Summer Street

  4. Nokia's Efficiency Pushes Share Price To 52-Week Highs

    Headlines

    Tue, 16 Sep 2014

    the company's gains. Nokia's price per share traded above $8.50, a new 52-week high, on Monday as analysts from Oppenheimer & Co. gave the company a $12 price target . Positive sentiment surrounding the company has picked up in 2014 as its networks

  5. Foamix Pharmaceuticals IPO Merits Serious Investor Consideration

    Headlines

    Tue, 16 Sep 2014

    on August 13, 2014 Lead Underwriters: Barclays Capital Inc; Cowen and Company, LLC Underwriters: Maxim Group, LLC; Oppenheimer and Co., Inc Summary: Strong, Diverse Pipeline For Skin Condition Treatments FOMX is a clinical-stage pharmaceutical

« Prev12345Next »
Content Partners